1Cohn JN, Fowler MB, Bristow M, et al. Safety and efficacy of carvedilol in severe heart failure[J] .J Card Fail, 1997,3(3): 173-179.
2The RESOLVD Investigators. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy[ J]. Circulation, 2000,101: 378 -384.
3Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery [ J ].Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med, 1996,335(23): 1713 - 1720.
4Salpeter SR, Ormiston TM, Salpeter EE, et al. Cardioselective betablockers for chronic obstructive pulmonary disease: a meta - analysis[J]. Respir Med,2003,97(10): 1094 - 1101.
5Kjekshus J, Gilpin E, Gali G, et al. Diabetic patients and beta blockers after acute myocardial infarction. Eur Heart J, 1990, 11 ( 1 ): 43 - 50.
6Chobanian AV, Bakris GL, Black HR , et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure[ J ]. JAMA, 2003,289 ( 19 ): 2560 - 2572.
7Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke. A statement for healthcare professionals from the Stroke Council of the American Heart Association[J]. Circulation,2001,103:163 - 182.
8Schobel HP, Langenfeld M, Gatzka C, et al.Treatment and post-treatment effects of alpha- versus beta- receptor blockers on left ventricular structure and function in essential hypertension[J]. Am Heart J, 1996,132(5): 1004-1009.
9Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology[J] .J Am Coll Cardiol,2003,41(1): 159 - 168.
10Antman EM, Anbe DT, Armtrong PW, et al. ACC/AHA2002 Guideline for the management of patients with ST - elevation myocardial infarction -executive summary: a report of the American College of Cardidogy [J].Circulation,2004,110(5) :588 - 636.
